Musaffa Logo
Takeda Pharmaceutical Co Ltd TKD.VI

Last Updated: Jul 14, 12:00 AM·WBAG

TKD.VI Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Takeda Pharmaceutical Co Ltd is classified as not halal.

NOT HALAL

Report Source: 2026 3rd Quarter Report

Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd. Stock Analysis TKD.VI

Austria Health Care Large Cap Report:
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!